Viewing Study NCT05803395


Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2026-01-02 @ 10:07 AM
Study NCT ID: NCT05803395
Status: UNKNOWN
Last Update Posted: 2023-11-28
First Post: 2023-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module